2nd Feb 2016 11:42
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
|
| ||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Skyepharma plc | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | √ | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| ||||
An event changing the breakdown of voting rights |
| ||||
Other (please specify): |
|
| |||
3. Full name of person(s) subject to thenotification obligation: iii | Aviva plc & its subsidiaries | ||||
4. Full name of shareholder(s) (if different from 3.):iv | Registered Holder:
BNY Norwich Union Nominees Limited 267,993*
Chase (GA Group) Nominees Limited 4,140,012*
State Street Nominees Limited 79,565*
Available on Request 130* * denotes direct interest Chase (GA Group) Nominees Limited 274,639 Chase Nominees Limited 136,578
Vidacos Nominees Limited 253,936
| ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 28 January 2016 | ||||
6. Date on which issuer notified: | 1 February 2016 | ||||
7. Threshold(s) that is/are crossed orreached: vi, vii | >5% to | ||||
8. Notified details: | |||||||
A: Voting rights attached to shares viii, ix | |||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||
Ordinary Shares GBP1GB00B3BFNB64 | 5,936,360 | 5,936,360 | 5,152,853 | 4,487,700 | 665,153 | 4.28% | 0.64% |
|
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction | ||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights |
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |
|
|
|
|
| Nominal | Delta |
|
|
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
5,152,853 | 4.92% |
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi |
The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited) · Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited) · Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited) · Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited) · Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited)
|
Proxy Voting: | |
10. Name of the proxy holder: | See Section 4 |
11. Number of voting rights proxy holder will ceaseto hold: |
|
12. Date on which proxy holder will cease to holdvoting rights: |
|
13. Additional information: | Figures are based on a total number of voting rights of 104,812,259 as per the Company's Completion of Capital Raising and Admission of New Shares of 29 April 2014.
|
14. Contact name: | Caroline Peace |
15. Contact telephone number: | 0207 881 1173 |
Related Shares:
AvivaSKP.L